Ladenburg Thalmann Financial Services’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,075
| Closed | -$142K | – | 5641 |
|
|
2019
Q2 | $142K | Sell |
3,075
-4,402
| -59% | -$124K | ﹤0.01% | 2718 |
|
|
2019
Q1 | $182K | Sell |
7,477
-1,985
| -21% | -$41.3K | ﹤0.01% | 2460 |
|
|
2018
Q4 | $135K | Buy |
9,462
+1,725
| +22% | +$26.2K | ﹤0.01% | 2538 |
|
|
2018
Q3 | $117K | Sell |
7,737
-877
| -10% | -$13.4K | ﹤0.01% | 2708 |
|
|
2018
Q2 | $140K | Hold |
8,614
| – | – | ﹤0.01% | 2511 |
|
|
2018
Q1 | $140K | Buy |
8,614
+4,470
| +108% | +$71.6K | ﹤0.01% | 2511 |
|
|
2017
Q4 | $53K | Sell |
4,144
-653
| -14% | -$7.43K | ﹤0.01% | 3183 |
|
|
2017
Q3 | $60K | Sell |
4,797
-277
| -5% | -$2.57K | ﹤0.01% | 2959 |
|
|
2017
Q2 | $42K | Sell |
5,074
-400
| -7% | -$3.27K | ﹤0.01% | 3159 |
|
|
2017
Q1 | $49K | Buy |
5,474
+1,668
| +44% | +$17.7K | ﹤0.01% | 2935 |
|
|
2016
Q4 | $33K | Sell |
3,806
-400
| -10% | -$2.94K | ﹤0.01% | 3158 |
|
|
2016
Q3 | $28K | Buy |
4,206
+244
| +6% | +$944 | ﹤0.01% | 3189 |
|
|
2016
Q2 | $14K | Sell |
3,962
-110
| -3% | -$358 | ﹤0.01% | 3590 |
|
|
2016
Q1 | $12K | Sell |
4,072
-169
| -4% | -$506 | ﹤0.01% | 3617 |
|
|
2015
Q4 | $18K | Sell |
4,241
-181
| -4% | -$826 | ﹤0.01% | 3312 |
|
|
2015
Q3 | $20K | Sell |
4,422
-52
| -1% | -$308 | ﹤0.01% | 3122 |
|
|
2015
Q2 | $32K | Sell |
4,474
-214
| -5% | -$1.58K | ﹤0.01% | 2913 |
|
|
2015
Q1 | $35K | Buy |
4,688
+760
| +19% | +$5.41K | ﹤0.01% | 2825 |
|
|
2014
Q4 | $19K | Buy |
3,928
+139
| +4% | +$550 | ﹤0.01% | 3030 |
|
|
2014
Q3 | $14K | Sell |
3,789
-34
| -0.9% | -$134 | ﹤0.01% | 2921 |
|
|
2014
Q2 | $17K | Sell |
3,823
-10,697
| -74% | -$44.2K | ﹤0.01% | 2791 |
|
|
2014
Q1 | $68K | Sell |
14,520
-9,111
| -39% | -$45.8K | ﹤0.01% | 1749 |
|
|
2013
Q4 | $118K | Buy |
23,631
+11,389
| +93% | +$62K | ﹤0.01% | 1369 |
|
|
2013
Q3 | $76K | Buy |
12,242
+2,242
| +22% | +$13.3K | ﹤0.01% | 1548 |
|
|
2013
Q2 | $45K | Buy |
+10,000
| New | +$53.8K | ﹤0.01% | 1808 |
|
Other funds holding ARRY
Ladenburg Thalmann Financial Services's ARRY Position: Q3 2019 in Review
Ladenburg Thalmann Financial Services sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 3,075 shares — an estimated $142K sold.
Ladenburg Thalmann Financial Services first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $182K in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Ladenburg Thalmann Financial Services reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Ladenburg Thalmann Financial Services sold 3,075 Array Biopharma Inc shares in Q3 2019, an estimated $142K.
- Ladenburg Thalmann Financial Services first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
- Ladenburg Thalmann Financial Services's Array Biopharma Inc position peaked at $182K in Q1 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.